{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:38:12Z","timestamp":1782131892989,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78705-8","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T10:11:39Z","timestamp":1731319899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The prognostic value and biological significance of MRI CE-T1-based radiomics models in CNS5-identified GBM: a multi-center study"],"prefix":"10.1038","volume":"14","author":[{"given":"Mingwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyuan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"78705_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017. Neuro Oncol. 22, iv1\u2013iv96 (2020).","journal-title":"Neuro Oncol."},{"key":"78705_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller, M. et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat. Rev. Clin. Oncol. 18, 170\u2013186 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"78705_CR3","doi-asserted-by":"crossref","unstructured":"Grochans, S. et al. Epidemiology of glioblastoma multiforme-literature review. Cancers 14 (2022).","DOI":"10.3390\/cancers14102412"},{"key":"78705_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11060-022-03960-6","volume":"157","author":"A Ramos-Fresnedo","year":"2022","unstructured":"Ramos-Fresnedo, A. et al. The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study. J. Neurooncol. 157, 177\u2013185 (2022).","journal-title":"J. Neurooncol"},{"key":"78705_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"78705_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/jnen\/nlaa059","volume":"79","author":"K Galbraith","year":"2020","unstructured":"Galbraith, K. et al. Molecular correlates of long survival in IDH-wildtype glioblastoma cohorts. J. Neuropathol. Exp. Neurol. 79, 843\u2013854 (2020).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"78705_CR7","doi-asserted-by":"crossref","unstructured":"Mirchia, K., Richardson, T. E. & Beyond IDH-mutation: emerging molecular diagnostic and prognostic features in adult diffuse gliomas. Cancers 12 (2020).","DOI":"10.3390\/cancers12071817"},{"key":"78705_CR8","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1007\/s00330-020-07089-w","volume":"30","author":"CJ Park","year":"2020","unstructured":"Park, C. J. et al. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas. Eur. Radiol. 30, 6464\u20136474 (2020).","journal-title":"Eur. Radiol."},{"key":"78705_CR9","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1007\/s00330-020-07335-1","volume":"31","author":"Y Choi","year":"2021","unstructured":"Choi, Y. et al. Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models. Eur. Radiol. 31, 2084\u20132093 (2021).","journal-title":"Eur. Radiol."},{"key":"78705_CR10","doi-asserted-by":"publisher","first-page":"791776","DOI":"10.3389\/fnins.2021.791776","volume":"15","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Radiomics analysis based on magnetic resonance imaging for preoperative overall survival prediction in isocitrate dehydrogenase wild-type glioblastoma. Front. Neurosci. 15, 791776 (2021).","journal-title":"Front. Neurosci."},{"key":"78705_CR11","doi-asserted-by":"crossref","unstructured":"Mayakonda, A. & Koeffler, H. P. Maftools: efficient analysis, visualization and summarization of MAF files from large-scale cohort based cancer studies. BioRxiv, 052662 (2016).","DOI":"10.1101\/052662"},{"key":"78705_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1148\/radiol.2018180200","volume":"289","author":"S Bae","year":"2018","unstructured":"Bae, S. et al. Radiomic MRI phenotyping of glioblastoma: improving survival prediction. Radiology. 289, 797\u2013806 (2018).","journal-title":"Radiology"},{"key":"78705_CR13","doi-asserted-by":"publisher","first-page":"666359","DOI":"10.3389\/fneur.2021.666359","volume":"12","author":"Y Yan","year":"2021","unstructured":"Yan, Y. et al. Topographic quadrant analysis of peripapillary superficial microvasculature in optic disc drusen. Front. Neurol. 12, 666359 (2021).","journal-title":"Front. Neurol."},{"key":"78705_CR14","doi-asserted-by":"crossref","unstructured":"Bologna, M. et al. Baseline MRI-radiomics can predict overall survival in non-endemic ebv-related nasopharyngeal carcinoma patients. Cancers 12 (2020).","DOI":"10.3390\/cancers12102958"},{"key":"78705_CR15","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1007\/s00330-022-08776-6","volume":"32","author":"F Chu","year":"2022","unstructured":"Chu, F. et al. Development and validation of MRI-based radiomics signatures models for prediction of disease-free survival and overall survival in patients with esophageal squamous cell carcinoma. Eur. Radiol. 32, 5930\u20135942 (2022).","journal-title":"Eur. Radiol."},{"key":"78705_CR16","doi-asserted-by":"publisher","first-page":"109631","DOI":"10.1016\/j.ejrad.2021.109631","volume":"138","author":"J Zhao","year":"2021","unstructured":"Zhao, J. et al. Development and validation of preoperative magnetic resonance imaging-based survival predictive nomograms for patients with perihilar cholangiocarcinoma after radical resection: a pilot study. Eur. J. Radiol. 138, 109631 (2021).","journal-title":"Eur. J. Radiol."},{"key":"78705_CR17","doi-asserted-by":"publisher","first-page":"100263","DOI":"10.1016\/j.jbo.2019.100263","volume":"19","author":"S Zhao","year":"2019","unstructured":"Zhao, S. et al. Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma. J. Bone Oncol. 19, 100263 (2019).","journal-title":"J. Bone Oncol."},{"key":"78705_CR18","doi-asserted-by":"publisher","first-page":"14435","DOI":"10.1038\/s41598-019-50849-y","volume":"9","author":"T Sasaki","year":"2019","unstructured":"Sasaki, T. et al. Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma. Sci. Rep. 9, 14435 (2019).","journal-title":"Sci. Rep."},{"key":"78705_CR19","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1007\/s00330-019-06069-z","volume":"29","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival. Eur. Radiol. 29, 5528\u20135538 (2019).","journal-title":"Eur. Radiol."},{"key":"78705_CR20","doi-asserted-by":"crossref","unstructured":"Park, Y. W. et al. Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation status. Eur. Radiol. (2022).","DOI":"10.14791\/btrt.2022.10.F-1059"},{"key":"78705_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.2019190913","volume":"294","author":"JE Park","year":"2020","unstructured":"Park, J. E. et al. Prediction of core signaling pathway by using diffusion- and perfusion-based MRI radiomics and next-generation sequencing in isocitrate dehydrogenase wild-type glioblastoma. Radiology. 294, 388\u2013397 (2020).","journal-title":"Radiology"},{"key":"78705_CR22","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1111\/cas.14918","volume":"112","author":"WY Huang","year":"2021","unstructured":"Huang, W. Y. et al. Radiological model based on the standard magnetic resonance sequences for detecting methylguanine methyltransferase methylation in glioma using texture analysis. Cancer Sci. 112, 2835\u20132844 (2021).","journal-title":"Cancer Sci."},{"key":"78705_CR23","doi-asserted-by":"publisher","first-page":"17228","DOI":"10.1016\/S0021-9258(17)32544-9","volume":"269","author":"JF Costello","year":"1994","unstructured":"Costello, J. F., Futscher, B. W., Tano, K., Graunke, D. M. & Pieper, R. O. Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J. Biol. Chem. 269, 17228\u201317237 (1994).","journal-title":"J. Biol. Chem."},{"key":"78705_CR24","doi-asserted-by":"crossref","unstructured":"Meng, W., Palmer, J. D., Siedow, M., Haque, S. J. & Chakravarti, A. Overcoming radiation resistance in gliomas by targeting metabolism and DNA repair pathways. Int. J. Mol. Sci. 23 (2022).","DOI":"10.3390\/ijms23042246"},{"key":"78705_CR25","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1038\/cddis.2013.171","volume":"4","author":"N Jiang","year":"2013","unstructured":"Jiang, N. et al. Valosin-containing protein regulates the proteasome-mediated degradation of DNA-PKcs in glioma cells. Cell. Death Dis. 4, e647 (2013).","journal-title":"Cell. Death Dis."},{"key":"78705_CR26","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1158\/0008-5472.CAN-14-3502","volume":"75","author":"N McCabe","year":"2015","unstructured":"McCabe, N. et al. Mechanistic rationale to target PTEN-deficient tumor cells with inhibitors of the DNA damage response kinase ATM. Cancer Res. 75, 2159\u20132165 (2015).","journal-title":"Cancer Res."},{"key":"78705_CR27","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1093\/nar\/gkab269","volume":"49","author":"S Kumamoto","year":"2021","unstructured":"Kumamoto, S. et al. HPF1-dependent PARP activation promotes LIG3-XRCC1-mediated backup pathway of Okazaki fragment ligation. Nucleic Acids Res. 49, 5003\u20135016 (2021).","journal-title":"Nucleic Acids Res."},{"key":"78705_CR28","doi-asserted-by":"publisher","first-page":"832343","DOI":"10.3389\/fonc.2022.832343","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Predicting chemo-radiotherapy sensitivity with concordant survival benefit in non-small cell lung cancer via computed tomography derived radiomic features. Front. Oncol. 12, 832343 (2022).","journal-title":"Front. Oncol."},{"key":"78705_CR29","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.18632\/aging.202328","volume":"13","author":"L Yi","year":"2021","unstructured":"Yi, L. et al. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas. Aging (Albany NY). 13, 3645\u20133660 (2021).","journal-title":"Aging (Albany NY)"},{"key":"78705_CR30","doi-asserted-by":"publisher","first-page":"101310","DOI":"10.1016\/j.tranon.2021.101310","volume":"16","author":"F Hyder","year":"2022","unstructured":"Hyder, F. & Khan, M. H. Dysregulated proton and sodium gradients highlight cancer invasion and proliferation. Transl Oncol. 16, 101310 (2022).","journal-title":"Transl Oncol."},{"key":"78705_CR31","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/brain\/awab340","volume":"145","author":"G Li","year":"2022","unstructured":"Li, G. et al. An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas. Brain. 145, 1151\u20131161 (2022).","journal-title":"Brain"},{"key":"78705_CR32","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.cell.2016.07.046","volume":"166","author":"D Daley","year":"2016","unstructured":"Daley, D. et al. Gammadelta T cells support pancreatic oncogenesis by restraining alphabeta T cell activation. Cell. 166, 1485\u20131499e1415 (2016).","journal-title":"Cell"},{"key":"78705_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1158\/0008-5472.CAN-14-3228","volume":"75","author":"M Rei","year":"2015","unstructured":"Rei, M., Pennington, D. J. & Silva-Santos, B. The emerging protumor role of gammadelta T lymphocytes: implications for cancer immunotherapy. Cancer Res. 75, 798\u2013802 (2015).","journal-title":"Cancer Res."},{"key":"78705_CR34","doi-asserted-by":"publisher","first-page":"e1277305","DOI":"10.1080\/2162402X.2016.1277305","volume":"6","author":"G Hu","year":"2017","unstructured":"Hu, G. et al. Tumor-infiltrating CD39(+)gammadeltaTregs are novel immunosuppressive T cells in human colorectal cancer. Oncoimmunology. 6, e1277305 (2017).","journal-title":"Oncoimmunology"},{"key":"78705_CR35","doi-asserted-by":"crossref","unstructured":"He, B. et al. Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker. J. Immunother Cancer 8 (2020).","DOI":"10.1136\/jitc-2020-000550"},{"key":"78705_CR36","first-page":"449","volume":"28","author":"Z Sun","year":"2020","unstructured":"Sun, Z. et al. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features. J. Xray Sci. Technol. 28, 449\u2013459 (2020).","journal-title":"J. Xray Sci. Technol."},{"key":"78705_CR37","doi-asserted-by":"publisher","first-page":"108451","DOI":"10.1016\/j.intimp.2021.108451","volume":"103","author":"F Yuan","year":"2022","unstructured":"Yuan, F. et al. BACH1 as a potential target for immunotherapy in glioblastomas. Int. Immunopharmacol. 103, 108451 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"78705_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/neuonc\/nox116","volume":"20","author":"L Jin","year":"2018","unstructured":"Jin, L. et al. CD70, a novel target of CAR T-cell therapy for gliomas. Neuro Oncol. 20, 55\u201365 (2018).","journal-title":"Neuro Oncol."},{"key":"78705_CR39","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/ijc.30830","volume":"141","author":"H Ge","year":"2017","unstructured":"Ge, H. et al. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM. Int. J. Cancer. 141, 1434\u20131444 (2017).","journal-title":"Int. J. Cancer"},{"key":"78705_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","volume":"86","author":"J Zeng","year":"2013","unstructured":"Zeng, J. et al. Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int. J. Radiat. Oncol. Biol. Phys. 86, 343\u2013349 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78705-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78705-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78705-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:15:41Z","timestamp":1731672941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78705-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78705"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78705-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors of this paper have read and approved the final version submitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27551"}}